Vycor Medical (VYCO) Share-based Compensation (2010 - 2025)
Vycor Medical's (VYCO) quarterly Share-based Compensation came in at $18315.0 in Q1 2025, up 674.75% year-on-year from $2364.0 in Q1 2024, and little changed on a QoQ basis from $18314.0 in Q4 2024.
Vycor Medical (VYCO) Share-based Compensation (2010 - 2025) Analysis & Trends
Vycor Medical (VYCO) has 16 years of Share-based Compensation data on file, last reported at $18315.0 in Q1 2025.
- On a quarterly basis, Share-based Compensation rose 674.75% year-over-year to $18315.0 in Q1 2025; TTM through Dec 2025 was $36629.0, a 77.14% increase from a year earlier, with the FY2025 full-year figure at $48838.0, changed 0.0% from the prior year.
- Share-based Compensation for Q1 2025 stood at $18315.0, roughly flat from $18314.0 in the prior quarter.
- Over the last five years, Share-based Compensation for VYCO reached as high as $122430.0 in Q1 2021 and fell as low as -$1771.0 in Q4 2022.
- Historically, Share-based Compensation has averaged $29575.4 across 5 years, with a median of $10682.0 in 2023.
- On a YoY basis, Share-based Compensation climbed as much as 67624.56% in 2022 and fell as far as 103.11% in 2022.
- Year by year, Share-based Compensation stood at $56996.0 in 2021, then tumbled by 103.11% to -$1771.0 in 2022, then jumped by 233.48% to $2364.0 in 2023, then surged by 674.7% to $18314.0 in 2024, then increased by 0.01% to $18315.0 in 2025.
- Per Business Quant data, the three most recent Share-based Compensation figures were $18315.0 in Q1 2025, $18314.0 in Q4 2024, and $2364.0 in Q1 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 317.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 139.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 95.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 83.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 45.40 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 35.80 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 35.12 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 35.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Vycor Medical | 2.34 Mn | 2.16 Mn | 375,153.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 18,315.00 |
| Mar 31, 2025 | 18,315.00 |
| Dec 31, 2024 | 18,314.00 |
| Dec 31, 2024 | 18,314.00 |
| Mar 31, 2024 | 2,364.00 |
| Mar 31, 2024 | 2,364.00 |
| Dec 31, 2023 | 2,364.00 |
| Dec 31, 2023 | 2,364.00 |
| Sep 30, 2023 | 2,363.00 |
| Sep 30, 2023 | 2,363.00 |
| Jun 30, 2023 | 2,364.00 |
| Jun 30, 2023 | 2,364.00 |
| Mar 31, 2023 | 3,050.00 |
| Mar 31, 2023 | 3,050.00 |
| Dec 31, 2022 | -1,771.00 |
| Dec 31, 2022 | -1,771.00 |
| Sep 30, 2022 | 59,835.00 |
| Sep 30, 2022 | 59,835.00 |
| Jun 30, 2022 | 76,978.00 |
| Jun 30, 2022 | 76,978.00 |